LearnGlossaryMarketStocksSuperinvestorsSign in

PRE

Prenetics Global Limited

Consumer Defensive · $390M market cap

Verdict

Share price

$20.17

close of Oct 3, 2026

Fair value

$26.64

Sticker Price

Payback Price

—

no buy price

Undervalued

PRE is Undervalued: at $20.17 it trades 24% below its fair value of $26.64. There's no buy price: it has lost money 3 years in a row, so its value rests on sales alone. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.

How we valued it

Sales-Based (P/S). It has reported a loss for 3 years in a row and doesn't produce cash consistently yet (0 of the last 3 years), so we value it on its sales.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-31.5% a year✗
Sales growth31.7% a year✓
Free cash flow growth307.7% a year✓
Return on invested capital-22.8%✗

Follow PRE

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Sep 3, 2026: no open-market purchases and 2 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

Leogrande Hudson Blake

director · 2026-09-04

Option exercise

2,000 shares

Tat Thuan Yen

VP, Finance of IM8 (US) LLC · 2026-09-03

Award

10,730 shares

About Prenetics Global Limited

Prenetics Global Limited is a consumer health sciences company that has pivoted to focus on a consumer health and longevity platform. The company's main brand is IM8, which offers science-backed nutritional supplements. It also operates CircleDNA, a consumer genetic testing brand that provides personalized health reports based on sequencing technology.

Household & Personal Products

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works